ELECTROGENIC TRANSPORT OF ORGANIC CATIONS AND BASES BY THE RENAL ORGANIC CATION TRANSPORTER OCT1

被引:0
|
作者
LANG, F
WALDEGGER, S
SUSSBRICH, H
ULZHEIMER, JC
GORBOULEV, V
KOEPSELL, H
BUSCH, AE
机构
[1] UNIV TUBINGEN,INST PHYSIOL,TUBINGEN,GERMANY
[2] UNIV TUBINGEN,INST ANAT,TUBINGEN,GERMANY
[3] UNIV WURZBURG,W-8700 WURZBURG,GERMANY
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:365 / 365
页数:1
相关论文
共 50 条
  • [11] Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2
    Gebauer, Lukas
    Jensen, Ole
    Brockmoeller, Juergen
    Duecker, Christof
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (18) : 12403 - 12416
  • [12] MORPHINE IS A SUBSTRATE OF THE ORGANIC CATION TRANSPORTER OCT1 AND POLYMORPHISMS IN THE OCT1 GENE AFFECT MORPHINE PHARMACOKINETICS.
    Tzvetkov, M. V.
    Stingl, J. C.
    Brockmoller, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S105 - S105
  • [13] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
    Shu, Yan
    Sheardown, Steven A.
    Brown, Chaline
    Owen, Ryan P.
    Zhang, Shuzhong
    Castro, Richard A.
    Ianculescu, Alexandra G.
    Yue, Lin
    Lo, Joan C.
    Burchard, Esteban G.
    Brett, Claire M.
    Giacomini, Kathleen M.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05): : 1422 - 1431
  • [14] Polymorphisms of Organic Cation Transporter1 (OCT1) in Indonesian Cancer Patients
    Perwitasari, Dyah Aryani
    Atthobari, Jarir
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 326 - 326
  • [15] Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics
    Shu, Y.
    Brown, C.
    Castro, R. A.
    Shi, R. J.
    Lin, E. T.
    Owen, R. P.
    Sheardown, S. A.
    Yue, L.
    Burchard, E. G.
    Brett, C. M.
    Giacomini, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 273 - 280
  • [16] The role of the organic cation transporter OCT1 in the hepatic uptake of thiamine and effects of OCT1 polymorphisms on thiamine pharmacokinetics in human
    Jensen, O.
    Matthaei, J.
    Mueller, J.
    Oswald, S.
    Brockmoeller, J.
    Tzvetkov, M. V.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S14 - S15
  • [17] The human organic cation transporter OCT1 and its role as a target for drug responses
    Brosseau, Nicolas
    Ramotar, Dindial
    DRUG METABOLISM REVIEWS, 2019, 51 (04) : 389 - 407
  • [18] Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
    Shu, Y
    Leabman, MK
    Feng, B
    Mangravite, LM
    Huang, CC
    Stryke, D
    Kawamoto, M
    Johns, SJ
    DeYoung, J
    Carlson, E
    Ferrin, TE
    Herskowitz, I
    Giacomini, KM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) : 5902 - 5907
  • [19] Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1
    Meyer, Marleen J.
    Neumann, Viktoria E.
    Friesacher, Hannah Rosa
    Zdrazil, Barbara
    Brockmoeler, Jurgen
    Tzvetkov, Mladen V.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (21) : 9890 - 9905
  • [20] EVALUATION OF ENDOGENOUS MONOAMINE NEUROTRANSMITTERS AS SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTER 1 (OCT1)
    Boxberger, Kelli
    Lampe, Jed N.
    DRUG METABOLISM REVIEWS, 2012, 44 : 136 - 136